Clients News • MC Services corporate website
paged,page-template-default,page,page-id-5522,paged-101,page-paged-101,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.7.0,vc_responsive




  • MagForce AG: Newly launched ’NanoTherm® Therapy School’ kicks off with successful first training session
  • MorphoSys Announces Appointment of David Trexler as President and Member of the Board of Directors of MorphoSys US Inc.
  • Motif Bio plc: Exercise of Warrants
  • NOXXON Pharma: new data published supporting monotherapy activity of CCL2 inhibitor NOX-E36 in an additional solid tumor type: liver cancer
  • Ergomed 2018 Trading Update
  • Biom’up appoints George Makhoul as Chief Commercial Officer (USA)
  • HPS Home Power Solutions GmbH announces launch of WIWIN crowdfunding campaign
  • Biom’up HEMOBLASTTM Bellows full pivotal trial results published in Journal of Cardiac Surgery
  • Rentschler Biopharma SE appoints Dr. Christian Hunzinger as Senior Vice President Project Management
  • Abivax Publishes in Nature Scientific Reports ABX464’s Unique Mechanism of Action Leading to Both Anti-Inflammatory and Antiviral Effects